2022 - Research.com Best Female Scientist Award
Her primary scientific interests are in Cancer, Genetics, Internal medicine, Melanoma and Oncology. Her Cancer research is multidisciplinary, incorporating elements of Odds ratio, Pathology, Genetic linkage and Genetic testing. Internal medicine is frequently linked to Surgery in her study.
Her work carried out in the field of Melanoma brings together such families of science as Dermatology, Hereditary Melanoma and Incidence. Margaret A. Tucker has researched Oncology in several fields, including Case-control study, Allele and Risk factor. Her Genome-wide association study research is multidisciplinary, incorporating perspectives in Linkage disequilibrium and Prostate cancer.
Her main research concerns Internal medicine, Oncology, Genetics, Cancer and Melanoma. Her work is dedicated to discovering how Oncology, Odds ratio are connected with Confidence interval and other disciplines. Her Cancer study incorporates themes from Disease, Pathology and Family history.
Margaret A. Tucker interconnects Dermatology and CDKN2A in the investigation of issues within Melanoma. Her CDKN2A research is multidisciplinary, relying on both Mutation and Germline mutation. Her work deals with themes such as Surgery and Incidence, which intersect with Epidemiology.
Internal medicine, Oncology, Melanoma, Genetics and Genome-wide association study are her primary areas of study. Her Internal medicine study deals with Hereditary Retinoblastoma intersecting with Cumulative incidence and Sarcoma. The various areas that she examines in her Oncology study include Odds ratio, Epidemiology, Young adult, Leukemia and Radiation therapy.
Her Melanoma study integrates concerns from other disciplines, such as Generalized estimating equation, Germline, Medical genetics, Familial Melanoma and Genotype. Her study on Genetics is mostly dedicated to connecting different topics, such as Mosaic. Margaret A. Tucker combines subjects such as Minor allele frequency and Locus with her study of Genome-wide association study.
Her primary areas of investigation include Internal medicine, Genetics, Single-nucleotide polymorphism, Oncology and Cancer. Her study in Relative risk and Survival rate are all subfields of Internal medicine. Her study in Single-nucleotide polymorphism is interdisciplinary in nature, drawing from both DNA microarray, Genotyping and Computational biology.
Her research investigates the link between Oncology and topics such as Proportional hazards model that cross with problems in Radiation therapy, Breast cancer, Epidemiology of cancer, Population study and Childhood Cancer Survivor Study. Her research brings together the fields of Epidemiology and Cancer. Her work in Epidemiology tackles topics such as Incidence which are related to areas like Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Jeffery P. Struewing;Patricia Hartge;Sholom Wacholder;Sonya M. Baker.
The New England Journal of Medicine (1997)
Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies
Elaine Ron;Jay H. Lubin;Roy E. Shore;Kiyohiko Mabuchi.
Radiation Research (1995)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J Hunter;David J Hunter;Peter Kraft;Kevin B Jacobs;David G Cox.
Nature Genetics (2007)
Germline p16 mutations in familial melanoma.
Christopher J. Hussussian;Jeffery P. Struewing;Alisa M. Goldstein;Paul A. T. Higgins.
Nature Genetics (1994)
A cancer family syndrome in twenty-four kindreds.
Frederick P. Li;Joseph F. Fraumeni;John J. Mulvihill;William A. Blattner.
Cancer Research (1988)
Replicating genotype–phenotype associations
Stephen J. Chanock;Teri Manolio;Michael Boehnke;Eric Boerwinkle.
Nature (2007)
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Meredith Yeager;Nick Orr;Richard B Hayes;Kevin B Jacobs.
Nature Genetics (2007)
Multiple loci identified in a genome-wide association study of prostate cancer
Gilles Thomas;Kevin B Jacobs;Meredith Yeager;Meredith Yeager;Peter Kraft.
Nature Genetics (2008)
Risk of second cancers after treatment for Hodgkin's disease.
M.A. Tucker;C.N. Coleman;R.S. Cox;A. Varghese.
The New England Journal of Medicine (1988)
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
Lin Zuo;John Weger;Qingbei Yang;Alisa M. Goldstein.
Nature Genetics (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
National Institutes of Health
National Institutes of Health
National Cancer Institute
National Institutes of Health
National Institutes of Health
St. Jude Children's Research Hospital
National Institutes of Health
Progenity (United States)
National Institutes of Health
University of Waterloo
University of Amsterdam
London School of Economics and Political Science
The University of Texas at Austin
Technical University of Munich
University of Valladolid
Harvard University
Ghent University
Carnegie Mellon University
John Innes Centre
Icahn School of Medicine at Mount Sinai
University of Miami
Dalhousie University
Goethe University Frankfurt
University of Milan
Washington State University